Sort by
Refine Your Search
-
, cutting-edge microscopy, immunology, technology development, and bioinformatics. VIB provides a highly interactive environment and ample training opportunities for its researchers. The VIB-UAntwerp Center
-
research environment operating at an international level Participation in a large European collaboration State-of-the-art research facilities A dedicated training program to broaden your expertise and
-
. By evaluating different quenching mechanisms (e.g., proximity-based singlet oxygen quenching and wavelength-specific energy transfer), this project seeks to develop novel insights into molecular
-
to arrange working at both host institutions (UAntwerp and KU Leuven), located ca. 50 km apart with a direct train connection in-between. What we offer We offer a doctoral scholarship for a period of 1 year
-
to neurodegenerative diseases of the central and peripheral nervous system, with an emphasis on understanding the genetic etiology and developing diagnostics and treatment methods for these diseases. Approaches range
-
talented PhD students to develop and benchmark cutting-edge super-resolution imaging technologies. The project aims to establish a comprehensive approach for ultra-high-content, multimodal imaging
-
-regulatory network analysis approaches, developed and employed in the Malysheva Lab, are required to reveal these mechanisms. With the proposed project we aim to bridge this gap in our knowledge of cis
-
, biochemistry, genomics, bacterial genetics and bioinformatics. You can work both independently as well as in an international team You can plan and perform laboratory experiments accurately You have strong
-
for doctoral scholarship holders on the pay scales for Contract Research Staff . Opportunities of career development (doctoral training) A stimulating and international research environment You will receive
-
/immunotherapies are insufficient due to resistance development and limited efficacy. Personalized medicine, focusing on novel prognostic and predictive biomarkers to identify patients that will respond to treatment